Skip to main content

Language: English / GĂ idhlig

Loading…

Chamber and committees

Question reference: S6W-00696

  • Asked by: Gordon MacDonald, MSP for Edinburgh Pentlands, Scottish National Party
  • Date lodged: 15 June 2021
  • Current status: Answered by Humza Yousaf on 29 June 2021

Question

To ask the Scottish Government how it will protect those who have been identified as not having any COVID-19 antibodies, despite having had both doses of the vaccination.


Answer

If an individual has specific concerns arising from the results of a test they have taken, including related to their immunological response following vaccination, they should consult their primary clinician, who can determine whether further investigation is necessary.

The results of serology (antibody) tests, while indicative, may not be definitive. The value of antibody tests is currently limited to answering the question of whether someone has had COVID-19 before and providing data and a greater understanding on the spread of the virus. An antibody test cannot tell you if you’re immune to COVID-19 or whether you can or cannot spread the virus to other people.

Some individuals may not develop a serologically detectable antibody response to vaccination. Additionally, vaccination does not have an immediate protective effect, but takes up to 3 weeks to produce an antibody response. This is particularly true for elderly, immunocompromised, or infirm people.

In addition to the individual level of protection against severe disease or hospitalisation afforded by vaccination, an additional benefit of the vaccination programme is to assist in developing widespread community immunity and thereby reduce the force of transmission and viral reproduction rate, controlling the prevalence of COVID-19. The inoculation of a large proportion of the population will help to provide a degree of passive protection in the community for those who may develop a weaker immune response, although further research into the impact on transmission is underway. The majority of those inoculated with two doses of vaccine develop a high level of protection.

Further research is being conducted on the effect of the vaccination programme on transmission both in relation to current and new variants of concern. Until we know more, it is essential that everyone continues to follow public health guidance and the COVID-19 protection level rules which apply in their Local Authority area.